目的：分析联合筋膜鞘(CFS)悬吊与提上睑肌(LM)缩短术矫正重度上睑下垂的效果及安全性。

方法：回顾性临床研究。选择本院2018-06/2022-06治疗的重度上睑下垂患者80例84眼，依据手术方式分成2组：CFS悬吊+LM缩短术组40例41眼采用CFS悬吊与LM缩短术； 额肌组40例43眼采用额肌肌瓣悬吊术。比较两组患者的临床总有效率、术后并发症产生以及患者满意率的情况。

结果：术后12 mo，CFS悬吊+LM缩短术组和额肌组患者临床有效率分别为98%和91%(P>0.05)。并发症发生率额肌组为26%(11/43)，CFS悬吊+LM缩短术组为7%(3/41)(P=0.024)。额肌组患者满意率为80%(32/40)，CFS悬吊+LM缩短术组为98%(39/40)(P=0.029)。

结论：采用CFS+LM术可有效地矫正重度上睑下垂，并发症较少，外观更贴近自然。

METHODS:Retrospective study. A total of 80 cases(84 eyes)of severe ptosis treated in our hospital from June 2018 to June 2022 were divided into two groups based on the surgical method, including 40 cases(41 eyes)underwent CFS suspension + LM shortening surgery in CFS group, and 40 patients(43 eyes)underwent frontal muscle flap suspension surgery in frontal muscle group; the clinical total effective rate, postoperative complications, and patient satisfaction rate of both groups of patients were compared.

RESULTS:At 12 mo postoperatively, the clinical effective rates of the two groups of patients were 98% and 91%, respectively(P>0.05). The incidence of complications was 26%(11/43)in the frontal muscle group and 7%(3/41)in the CFS group(P=0.024). The satisfaction rate of the frontal muscle group was 80%(32/40), while the CFS group was 98%(39/40; P=0.029).

CONCLUSION:The use of CFS+LM surgery can effectively correct severe ptosis, with fewer complications and a more natural appearance.